Home › NDC Lookup › Ingredients › Belladonna, Bryonia (Alba), Chamomilla,... › 43689-0017-02
Migraine Relief Belladonna, Bryonia (Alba), Chamomilla, Cimicifuga Racemosa, Coffea Cruda, Glonoinum, Iris Versicolor, Natrum Muriaticum, Passiflora Incarnata, Valeriana Officinalis 6 [hp_X]/1; 6 [hp_X]/1; 3 [hp_X]/1; 6 [hp_X]/1; 3 [hp_X]/1; 12 [hp_X]/1; 6 [hp_X]/1; 6 [hp_X]/1 Tablet, 90-count — NDC 43689-0017-02 package photo

Migraine Relief Belladonna, Bryonia (Alba), Chamomilla, Cimicifuga Racemosa, Coffea Cruda, Glonoinum, Iris Versicolor, Natrum Muriaticum, Passiflora Incarnata, Valeriana Officinalis 6 [hp_X]/1; 6 [hp_X]/1; 3 [hp_X]/1; 6 [hp_X]/1; 3 [hp_X]/1; 12 [hp_X]/1; 6 [hp_X]/1; 6 [hp_X]/1 Tablet, 90-count

by The Magni Company · 1 BOTTLE in 1 CARTON (43689-0017-2) / 90 TABLET in 1 BOTTLE (43689-0017-1)
NDC 43689-0017-02
🏷️ FDA NDC (as labeled) 43689-0017-2 billing pads the package segment with a zero
OTC On market Non-controlled
🗂️ Data synced Sep 17, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 43689-0017-2
Product NDC 43689-0017
11-digit billing NDC 43689001702
UNII WQZ3G9PF0H, T7J046YI2B, G0R4UBI2ZZ, K73E24S6X9, 3SW678MX72, G59M7S0WS3 +4 more
SPL Set ID 79b25c52-e145-4ee5-af2e-1ccf6ad5ac2d
Established class (EPC) Non-Standardized Food Allergenic Extract; Non-Standardized Plant Allergenic Extract; Nitrate Vasodilator
Physiologic effect Increased Histamine Release; Cell-mediated Immunity; Vasodilation
Chemical class Allergens; Dietary Proteins; Plant Proteins; Seed Storage Proteins; Nitrates
DEA schedule Non-controlled
Marketing category UNAPPROVED HOMEOPATHIC
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2014-07-17
Route ORAL
Dosage form TABLET
Substance ATROPA BELLADONNA; BRYONIA ALBA ROOT; MATRICARIA CHAMOMILLA WHOLE; BLACK COHOSH; ARABICA COFFEE BEAN; NITROGLYCERIN; IRIS VERSICOLOR ROOT; SODIUM CHLORIDE; PASSIFLORA INCARNATA FLOWERING TOP; VALERIAN
Why two NDCs? The FDA registers this code as 43689-0017-2 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 43689-0017-02. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏭 Manufacturer & labeler

LabelerThe Magni Company
Labeler code43689
First marketedJul 2014
Product typeHuman Otc Drug
Portfolio10 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

🧪 What is this product?

This is an unapproved homeopathic tablet taken by mouth that contains ten plant and mineral substances. In homeopathic tradition, these ingredients are used to address symptoms associated with migraines and headaches. The formula includes substances such as belladonna, chamomilla, and valerian, which in homeopathic practice are thought to help with various pain and discomfort patterns. Homeopathic products are marketed based on traditional use; the FDA does not evaluate them for effectiveness or safety in the way it does other medications.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color white
ShapeRound
ImprintML
Size6 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII J2B2A4N98G
    Lactose is a natural sugar derived from milk. In medications, it serves as a filler and binder to add bulk and help hold tablet or capsule ingredients together during manufacturing.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.

3 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesLactose, Magnesium Stearate, Microcrystaline Cellulose.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Migraine Relief 6 [hp_X]/1; 6 [hp_X]/1; 3 [hp_X]/1; 6 [hp_X]/1; 3 [hp_X]/1; 12 [hp_X]/1; 6 [hp_X]/1; 6 [hp_X]this 43689-0017-02 The 90 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2014
On the market since
Jul 2014
📍
2026
Currently FDA-listed
12 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Migraine Relief (this brand).

Top reported reactions

Pain15,072
Fatigue14,479
Nausea13,516
Headache12,099
Arthralgia10,927
Dyspnoea10,540
Vomiting9,979

Age at onset

Neonate574
Infant287
Child1,272
Adolescent1,335
Adult21,472
Elderly7,053

Reporter sex

198,435 reports
Male · 35%
Female · 64%
Unknown · 0%

Serious outcomes

Hospitalization70,582
Life-threatening13,207
Disabling9,156
Reports over time (by year) — tap or hover for the count & year
2021 2022 2024 2026 15,251 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
43689-0017-02 You're viewing this 1 BOTTLE in 1 CARTON (43689-0017-2) / 90 TABLET in 1 BOTTLE (43689-0017-1) 2014-07-17 Active

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product Homeopathic listing

About homeopathic listings

Migraine Relief Belladonna, Bryonia (Alba), Chamomilla, Cimicifuga Racemosa, Coffea Cruda, Glonoinum, Iris Versicolor, Natrum Muriaticum, Passiflora Incarnata, Valeriana Officinalis 6 [hp_X]/1; 6 [hp_X]/1; 3 [hp_X]/1; 6 [hp_X]/1; 3 [hp_X]/1; 12 [hp_X]/1; 6 [hp_X]/1; 6 [hp_X]/1 TABLET is listed under the homeopathic marketing category. An NDC listing in this category does not by itself establish FDA approval, and FDA does not evaluate homeopathic products for effectiveness. This page reports the listing data as published.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Homeopathic". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 43689-0017-2, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 43689-0017-02, written without dashes as 43689001702. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 43689-0017-02, the first segment (43689) is the labeler code FDA assigned to The Magni Company; the middle segment (0017) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (02) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by The Magni Company. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
The Magni Company is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 16 words ▾

USES: Temporarily relieves acute symptoms of migraine headaches such as: •pressure •pulsating •stabbing headache •nausea •sensitivity

⏱️ Dosage and Administration 42 words ▾

DIRECTIONS: Adults and children 12 years and above: Dissolve 2 tablets under tongue 2 to 3 times daily or as directed by a physician. Children under 12 years: consult a physician Take at least 10 minutes before or after eating or drinking.

⚠️ Warnings 122 words ▾

WARNINGS: If pregnant or breastfeeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Use only after diagnosis by a physician. This product is intended to complement, not replace, proper medical attention. Stop use and ask a doctor if you experience worsening symptoms or if symptoms last longer than 7 days.

Other Information Store tightly closed in dry place. Tamper Sealed: Sealed for your protection. Do not use if seal is broken or missing.

The letters "HPUS" indicate that the components in this product are officially monographed in the Homeopathic Pharmacopeia of the United States. These statements are supported by the traditional homeopathic principles.

🧪 Active Ingredient 39 words ▾

ACTIVE INGREDIENTS: Belladonna 6X, 12X, Bryonia (Alba) 6X, 12X, 18X, Chamomilla 3X, Cimicifuga Racemosa 6X, 12X, 18X, Coffea Cruda 3X, Glonoinum 12X, 18X, Iris Versicolor 6X, 12X, 18X, Natrum Muriaticum 6X, 12X, 18X, Passiflora Incarnata 3X, Valeriana Officinalis 3X

🧪 Inactive Ingredients 7 words ▾

INACTIVE INGREDIENTS: Lactose, Magnesium Stearate, Microcrystaline Cellulose.

🎯 Purpose 16 words ▾

USES: Temporarily relieves acute symptoms of migraine headaches such as: •pressure •pulsating •stabbing headache •nausea •sensitivity

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 43689-0016-02 · Magni 43689-0018-02 · The →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.